Area of research
Epidemiology · Genetics
Research interest
Research interests include Meningioma and schwannoma management, Glioma Diagnosis and Treatment, Neurofibromatosis and Schwannoma Cases, and Brain Metastases and Treatment.
Advancing CNS tumor diagnostics with expanded DNA methylation-based classification
Molecular signatures define <i>BAP1</i>-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genes
IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spread
Advancing CNS tumor diagnostics with expanded DNA methylation-based classification
Molecular analysis of adolescent and young adult high grade gliomas in the SPECTA-AYA study: Poorly characterised tumours with frequent germline alterations
A framework for using DNA methylation-based modelling for the clinical management of cranial meningioma
A spatial map of MAPK-activated immunosuppressive myeloid populations in pediatric low-grade glioma
Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients
Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma
European Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selection
Microglia mediate neurocognitive deficits by eliminating C1q-tagged synapses in sepsis-associated encephalopathy
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses
Intraoperative microscopic autofluorescence detection and characterization in brain tumors using stimulated Raman histology and two-photon fluorescence
Pediatric meningiomas: A literature review and diagnostic update
The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study
ATRT–SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significance
MEDB-04. Young children with metastatic medulloblastoma: frequent requirement for radiotherapy in children with non-WNT/non-SHH medulloblastoma despite highly intensified chemotherapy – Results of the MET-HIT2000-BIS4 trial
EANO guideline on the diagnosis and management of meningiomas
Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors
Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)
Molecular profiling of pediatric meningiomas shows tumor characteristics distinct from adult meningiomas
Integrated phospho-proteogenomic and single-cell transcriptomic analysis of meningiomas establishes robust subtyping and reveals subtype-specific immune invasion
Recurrent fusions in <i>PLAGL1</i> define a distinct subset of pediatric-type supratentorial ependymoma
PATH-39. INTEGRATED MOLECULAR-MORPHOLOGICAL MENINGIOMA CLASSIFICATION: A MULTICENTER RETROSPECTIVE ANALYSIS, RETRO- AND PROSPECTIVELY VALIDATED
CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas
Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort
Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1
MBCL-07. NON-METASTATIC MEDULLOBLASTOMA OF EARLY CHILDHOOD: RESULTS FROM THE PROSPECTIVE CLINICAL TRIAL HIT-2000 AND AN EXTENDED VALIDATION COHORT
Glutamatergic synaptic input to glioma cells drives brain tumour progression
DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management